Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Current status of pyrazoloacridine as an anticancer agent
Alex A. Adjei
Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
42
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current status of pyrazoloacridine as an anticancer agent'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
NSC 366140
100%
Antineoplastic Agents
47%
Acridines
15%
Multidrug Resistance-Associated Proteins
14%
Topoisomerase I Inhibitors
14%
Type II DNA Topoisomerase
12%
Neoplasms
12%
DNA Adducts
12%
Gastrointestinal Neoplasms
11%
ATP Binding Cassette Transporter, Subfamily B, Member 1
10%
Prostatic Neoplasms
7%
Child
4%